IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3631 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (35 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References

 Article Access Statistics
    Viewed5229    
    Printed50    
    Emailed1    
    PDF Downloaded192    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 


 
NET LETTER
Year : 2008  |  Volume : 74  |  Issue : 3  |  Page : 298

Comparison of two diluents of 1% methoxsalen in the treatment of vitiligo


Consultant Dermatologist, Shree Skin Center and Laboratory, Mumbai, India

Correspondence Address:
Kiran V Godse
Shree Skin Center and Laboratory, 21/22, L market, Sector 8, Nerul, Navi Mumbai - 400 706
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.41405

Rights and Permissions



How to cite this article:
Godse KV. Comparison of two diluents of 1% methoxsalen in the treatment of vitiligo. Indian J Dermatol Venereol Leprol 2008;74:298

How to cite this URL:
Godse KV. Comparison of two diluents of 1% methoxsalen in the treatment of vitiligo. Indian J Dermatol Venereol Leprol [serial online] 2008 [cited 2019 Oct 17];74:298. Available from: http://www.ijdvl.com/text.asp?2008/74/3/298/41405


Sir,

The major nonsurgical repigmenting therapies for vitiligo include psoralens and corticosteroids, used both topically and systemically. [1] Around 1% of the world's population has vitiligo, which causes a patchy loss of skin color. The methods currently available to treat vitiligo are largely unsatisfactory and vary widely between cultures and within health systems. [2] Potent topical steroids used along with psoralens and ultraviolet or sun exposure are the most effective forms of therapy for localized vitiligo.

This study was done to evaluate a new diluent in the treatment of vitiligo. Traditionally, eau de cologne or spirit or water is used to dilute methoxsalen for topical PUVA therapy. Eau de Cologne contains a mixture of citrus oils, including oils of lemon, orange, tangerine, bergamot, lime, grapefruit, and nerolin, in a base of dilute ethanol (70-90%).

Ten patients with essentially bilateral and symmetrical lesions were enrolled in a randomized, right/left comparative study of 2 months' duration. Ten patients (6 females and 4 males) in the age-group of 15-50 years were included in this study; all of the subjects had localized vitiligo, affecting less than 20% of the body surface area. The average age of the patients was 29.8 years (range 15-50 years) and they had had vitiligo for 2-4 years (average 1.7 years). Lips and tips variety of vitiligo was not included. Pregnant and lactating mothers were not included.

For therapy we used a topical psoralen, 1% methoxsalen, diluted with lipid-free lotion (Cetaphil lotion, Galderma Laboratories) on the right side of the body and with eau de cologne on left side of body.

Cetaphil lotion is composed of cetyl alcohol (2.65%) and stearyl alcohol (0.26%) in a propylene glycol base. Clobetasol propionate cream (0.05%) was applied in the night for all patients. All patients were advised to dilute 1% methoxsalen lotion with lipid-free lotion (Cetaphil lotion) for use on the right side and with a similar amount of eau de cologne for use on the left side of body; this was to be applied with a brush on the affected area on alternate days 30 min before sun exposure between 10 am to 2 pm. Sun exposure was initially for 2 min and was gradually increased by 1 min every 10 days. After sunlight exposure, the treated areas were cleaned with soap and water.

Three patients (30%) reported irritation, redness, and itching on the eau de cologne side after 3 weeks, whereas there were no symptoms reported on the lipid-free lotion (Cetaphil) side till the end of the 2-month study period. Cetaphil lotion was well tolerated as a diluent compared to eau de cologne, which is traditionally used in therapy. Later, eau de cologne was replaced with Cetaphil lotion till the completion of the study. At the end of 2 months, more than 50% repigmentation was observed in four patients and between 25-50% repigmentation was observed in another five patients. One patient was lost to follow-up.

Lipid-free cleansing lotions, which contain fatty alcohols, were designed for people with sensitive or dry skin. These lotions can be wiped off without the use of water. One advantage of these agents is that the fatty alcohol component facilitates evaporation and thus is associated with less facial residue than classic soaps. These agents also contain emollients (e.g., fatty alcohols) and/or humectants (e.g., propylene glycol) to counter the irritating effects or drying potential of the surfactant ingredient. [3] It has been suggested that soaps and other skin cleansers with an alkaline pH may impair the lipid bilayer of the stratum corneum barrier and thus cause dry skin. [4] Cetaphil contains the humectant propylene glycol and fatty acid alcohol emollients, both of which can enhance hydration of the stratum corneum. This hydration can enhance topical drug penetration. [5] Another study showed that Cetaphil lotion caused significantly less irritation compared with Purpose , Ivory , and Alpha Keri . [6] In one study, Cetaphil lotion was preferred over hydrophilic ointment for cosmetic reasons and was clinically equally effective in PUVA therapy for palmoplantar psoriasis. [7] Lipid-free lotion (Cetaphil lotion) was well accepted by patients as a diluent in this study.

 
  References Top

1.Handa S, Pandhi R, Kaur I. Vitiligo: A retrospective comparative analysis of treatment modalities in 500 patients. J Dermatol 2001;28:461-6.  Back to cited text no. 1  [PUBMED]  
2.Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U. Interventions for vitiligo. Cochrane Database Syst Rev 2006;1:CD003263.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]
3.Bikowski J. The use of cleansers as therapeutic concomitants in various dermatologic disorders. Cutis 2001;68:12-9.  Back to cited text no. 3  [PUBMED]  
4.Schmid MH, Korting HC. The concept of the acid mantle of the skin: Its relevance for the choice of skin cleansers. Dermatology 1995;191:276-80.  Back to cited text no. 4    
5.Lippold BC. How to optimize drug penetration through the skin. Pharm Acta Helv 1992;67:294-600.  Back to cited text no. 5  [PUBMED]  
6.Mills OH Jr, Berger RS, Baker MD. A controlled comparison of skin cleansers in photo aged skin. J Geriatr Dermatol 1993;1:173-8.  Back to cited text no. 6    
7.Abel EA, Goldberg LH, Farber EM. Treatment of palmoplantar psoriasis with topical methoxsalen plus long wave ultraviolet light. Arch Dermatol 1980;116:1257-61.  Back to cited text no. 7  [PUBMED]  



This article has been cited by
1 Topical treatment in vitiligo and the potential uses of new drug delivery systems
Garg, B.J., Saraswat, A., Bhatia, A., Katare, O.P.
Indian Journal of Dermatology, Venereology and Leprology. 2010; 76(3): 231-238
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow